On February 7, 2014, China Food and Drug Administration (CFDA) issued the Special Review and Approval Procedure for Innovative Medical Devices (interim), which will be put into force as of March 1, 2014. The Procedure is an approval channel for innovative medical devices under the precondition of ensuring the safety and effectiveness of marketed products.